Physician profile
Clinton Anthony
NPI 1528061603
$1,031.50
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $129 · 2022: $379.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $208.78 | 2019 | |
| Spr Therapeutics, INC | $205.64 | 2022 | |
| Medtronic, INC. | $173.27 | 2022 | |
| Nevro Corp. | $136.00 | 2019-2020 | |
| Pfizer INC. | $130.15 | 2019 | |
| Allergan, INC. | $39.60 | 2019 | |
| Collegium Pharmaceutical, INC. | $33.93 | 2020 | |
| Horizon Therapeutics Plc | $24.23 | 2019 | |
| Acell, INC. | $21.93 | 2019 | |
| Amgen INC. | $18.89 | 2019 | |
| Pacira Therapeutics, INC. | $14.07 | 2019 | |
| Medtronic USA, INC. | $13.00 | 2019 | |
| Mdd US Operations, LLC | $12.01 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clinton Anthony listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.